±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 594  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

liuyuanzuo

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖú£¬ÁÙ´²ÊÔÑé·­Òë

According to Article 1(3) of Directive 2005/28/EC a specific modality related
to handling of investigational medicinal products where provisions laid down
by Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) are
not practicable may be accepted. Therefore, a sponsor may put in place
arrangements with the pharmacist and the investigator to ensure, as far as
possible, that specific accountability procedures and records for the trial been
adopted. This includes documentation in the patient¡¯s medical chart or other
source document, e.g. the patient¡¯s diary, and/or the case report form. The
pharmacy's and the investigator¡¯s procedures and records should allow
adequate re-construction of investigational medicinal product movements and
administration, having regard to the purpose of the trial. It should at least
include a procedure to record which  patients received which investigational
medicinal products during the trial with an evaluation of the compliance.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangzx1314

½û³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
liuyuanzuo: ½ð±Ò+15, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÐÁ¿àÄãÁË£¡£¡·Ç³£¸Ðл£¡ 2013-07-29 08:25:11
×Ô¼ºµÄ·­Ò룬Íû²ÉÄÉ~~~~
      ¸ù¾ÝµÚ1Ìõ(3)2005/28/ECÖ¸ÁҩƷÉú²úÖÊÁ¿¹ÜÀí¹æ·¶£¨GMP£©ºÍÒ©Æ·ÁÙ´²ÊµÑé¹ÜÀí¹æ·¶ÖÐÖ¸³ö²»¿ÉÐеÄÁÙ´²ÊÔÑéÒ©Æ·µÄ¾ßÌåÎïÀíÁÆ·¨ÊǿɽÓÊܵġ£Òò´Ë£¬ÔÞÖúÉÌ¿ÉÄܺÍÒ©¼ÁʦÒÔ¼°µ÷²éÔ±ÍÆ³ö´ëÊ©À´¾¡¿ÉÄܵØÈ·±£¾ßÌåÎÊÔð³ÌÐòºÍ¼Ç¼ÊÔÑéµÄʵʩ¡£µ±ÖаüÀ¨²¡È˲¡ÀúÒÔ¼°ÆäËüÔ´Îĵµ¡£±ÈÈ粡ÈËÈռǺÍ/»òÕß²¡Àú¼Ç¼±í¡£Ò©·¿ºÍµ÷²éÕߵijÌÐòºÍ¼Ç¼Ӧ¸ÃÔÊÐíÁÙ´²ÊÔÑéÒ©Æ·¸ù¾ÝÊÔÑéÄ¿µÄ½øÐе÷ÅäºÍ¹ÜÀí¡£ËüÖÁÉÙÓ¦¸ÃÓÐÒ»¸ö³ÌÐòÀ´¼Ç¼ÔÚÊÔÑé¹ý³ÌÖÐÄÄÒ»¸ö²¡È˽ÓÊÜÁËÄÄÒ»ÖÖÁÙ´²ÊÔÑéÒ©Æ·£¬²¢¶ÔÆä½øÐкϹæÐÔÆÀ¹À¡£
2Â¥2013-07-28 16:12:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ liuyuanzuo µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +8 Ò»ÑùYWY 2026-04-03 8/400 2026-04-03 21:46 by lbsjt
[¿¼ÑÐ] 295Çóµ÷¼Á +6 FZAC123 2026-04-03 6/300 2026-04-03 21:01 by zhq0425
[¿¼ÑÐ] 310Çóµ÷¼Á +18 ÕùÈ¡¾Åµã˯ 2026-03-30 18/900 2026-04-03 18:35 by lsÁõ˧
[¿¼ÑÐ] ÎåÒØ´óѧÍÁľ¹¤³ÌÕе÷¼ÁÉú2026 +3 wyutj 2026-03-31 4/200 2026-04-03 18:21 by zengxj_7201
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +7 ÏàÐűػá¹ââÍòÕ 2026-04-02 7/350 2026-04-03 16:48 by rzh123456
[¿¼ÑÐ] Çóµ÷¼Á²»Ìôרҵ +3 xrh030412 2026-04-01 3/150 2026-04-03 14:40 by µªÆøÆøÆø
[¿¼ÑÐ] 289-Çóµ÷¼Á +4 ÕâÀïÊÇ_ 2026-04-03 4/200 2026-04-03 14:23 by 1753564080
[¿¼ÑÐ] 275Çóµ÷¼Á +14 waltzh 2026-04-01 14/700 2026-04-03 11:24 by qqq850810
[¿¼ÑÐ] ±¾¿ÆÐÂÄÜÔ´¿ÆÑ§Ó빤³Ì£¬Ò»Ö¾Ô¸»ªÀíÄܶ¯285Çóµ÷¼Á +9 AZMK 2026-03-28 13/650 2026-04-03 11:18 by qqq850810
[¿¼ÑÐ] ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé +8 shzhou_ 2026-04-01 9/450 2026-04-03 09:31 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á +5 Ã÷×С¤ 2026-04-01 7/350 2026-04-02 11:17 by ×Þξξ
[¿¼ÑÐ] 372Çóµ÷¼Á +3 jjÓ¿77 2026-04-02 3/150 2026-04-02 09:57 by olim
[¿¼ÑÐ] 279Çóµ÷¼Á +7 Īxiao 2026-04-01 7/350 2026-04-01 22:05 by ¿Í¶ûÃÀµÂ
[¿¼ÑÐ] 379Çóµ÷¼Á +3 ?¿à¹Ï²»¿à 2026-04-01 3/150 2026-04-01 20:09 by ÄºÔÆÇ庮
[¿¼ÑÐ] 350Çóµ÷¼Á +7 °¢¼Ñ¡« 2026-03-31 7/350 2026-04-01 16:12 by yanflower7133
[¿¼ÑÐ] ¿¼ÑвÄÁϹ¤³Ì351·Öµ÷¼Á +5 Õû¸öºÃµÄ 2026-03-31 5/250 2026-04-01 09:36 by topgun2009
[¿¼ÑÐ] 254²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +3 º²¶¬ÁÖéª 2026-03-30 4/200 2026-03-31 17:53 by yishunmin
[¿¼ÑÐ] һ־ԸʳƷ¿ÆÑ§Ó빤³Ì083200Çóµ÷¼Á +4 XQTJZ 2026-03-30 4/200 2026-03-31 04:10 by fmesaito
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
[¿¼ÑÐ] һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á +4 ÐÒÔ˵ÄÈýľ 2026-03-29 5/250 2026-03-29 14:49 by Miko19
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û